Investigation of a new implant surface modification using phosphorylated pullulan

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Dental Implantology

Background:

• Osseointegration failure remains a challenge in dental implantology.
• Current surface treatments do not guarantee successful osseointegration.
• A novel material is needed to improve implant-bone bonding and regeneration.

Purpose of the Study:

• To evaluate phosphorylated pullulan as a novel surface treatment for titanium (Ti) implants.
• To assess the biocompatibility and bone-promoting properties of phosphorylated pullulan.
• To investigate its potential as a drug delivery system for bone morphogenetic protein-2 (BMP-2).

Main Methods:

• Cultured osteoblast-like cells (Saos-2, MC3T3-E1) and macrophage-like cells (RAW264.7) with phosphorylated pullulan.
• Assessed cell proliferation and calcification on Ti disks coated with phosphorylated pullulan.
• Evaluated BMP-2 loaded phosphorylated pullulan for enhanced calcification and inhibition of osteoclast formation.

Main Results:

• Phosphorylated pullulan promoted osteoblast-like cell proliferation and calcification on Ti disks.
• BMP-2 loaded phosphorylated pullulan significantly enhanced calcification.
• Phosphorylated pullulan inhibited osteoclast-like cell formation, suggesting reduced bone resorption.

Conclusions:

• Phosphorylated pullulan demonstrates excellent adhesiveness to titanium and bone, promoting osseointegration.
• Its biocompatibility and drug-loading capacity make it a promising candidate for new implant surface treatments.
• This material effectively supports bone regeneration and may reduce implant failure rates.